Central retinal vein thrombosis associated with prothrombin 20210G/A gene variant

Clinical and Applied Thrombosis/Hemostasis

Volumn 5, Issue 3, 1999, Pages 190-191

  Vayá, Amparo ^a   López, José Ma ^b   Mira, Yolanda ^b   Ricart, José Ma ^b   Villa, Piedad ^b   España Gregori, Enrique ^a   Estellés, Amparo ^a   Aznar, Justo ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b La Fe University Hospital ^*

Author keywords

20210A allele; Prothrombin gene; Retinal vein thrombosis

Indexed keywords

PROTHROMBIN;

ADULT; ARTICLE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; DISEASE ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BLOOD LEVEL; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS;

EID: 0345551949     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969900500310     Document Type: Article

References (10)

1. Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 1989;21:153.
2. Williamson TH, Rumley A, Lowe GDO. Blood viscosity coagulation and activated protein C resistance in central retinal vein occlusion; a population controlled study. Br J Ophthalmol 1996; 80:203.
3. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996;80:200.
4. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variant in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood 1996;88:3698.
5. Rosendaal Fr, Doggen CJM, Zivelin A, et al. Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost 1998;79:706.
6. Delahousse B, Arséne S, Piquemal R, et al. The 20210 A allele of the prothrombin gene is not a risk factor for retinal vein occlusion. Blood Coagul Fibrinolysis 1998;9:447.
7. Albisinni R, Coppola A, Loffredo M, et al. Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 1998;80:702.
8. Kapur RK, Mills LA, Spitzer SG, Hultin MB. A prothrombin gene mutation is significantly associated with venous thrombosis. Arterioscler Thromb Vasc Biol 1997;17:2875.
9. Souto JC, Coll I, Llobet D, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998;80:366.
10. Aznar J, Vayá A, Estellés A, et al. Estudio de la protrombina 20210G/A y factor V Leiden en pacientes con trombofilia y con trombosis venosa profunda no seleccionados [Abstract]. Rev Iberoamer Tromb Hemost 1998;XI(Suppl 1):118.